INTRODUCTION
The human parvovirus B19 was originally described by Cossart et al. (1975) and was found independently in two other laboratories (Okochi et al., 1984; Courouc6 et al., 1984) . It is a virus that commonly infects children, causing erythema infectiosum (fifth disease or slapped cheek syndrome) as shown by Anderson et al. (1983) and Plummer et al. (1985) . In patients with haemolytic diseases B19 infection may precipitate an aplastic crisis . There are a variety of other outcomes of infection, particularly in adults. These include asymptomatic infection, fever, purpura, vasculitis, arthritis and hydrops fetalis (Shneerson et al., 1980; Lefrere et al., 1985b; Li Loong et al., 1986; Cohen et al., 1986; Anand et al., 1986) .
Initial experiments suggested that B19 viral particles contain ssDNA of either polarity which anneals on chemical extraction to form double-stranded molecules (Summers et al., 1983; Clewley, 1984) . More detailed work established that the genome is a 5.54 kb linear molecule with self-priming hairpin termini (Cotmore & Tattersall, 1984) . Most of the nucleotide sequence of two isolates has been determined (Shade et al., 1986; Blundell et al., 1987) . The ends of the viral DNA were not completely sequenced, but it is likely that they are inverted repeats.
Different B 19 isolates appear antigenically identical in immunodiffusion tests (Serjeant et al., 1981 ; Okochi et aL, 1984) , although it may be possible to distinguish between them by using monoclonal antibodies. Alternatively, the extent of strain variation or genomic diversity of different isolates of B19 can be studied by restriction enzyme mapping. Morinet et al. (1986) analysed 17 isolates with eight enzymes and found that 13 had the same map, the other four having altered sites for one or more enzyme. We have also mapped the sites where selected enzymes cut B19 DNA. This was both to determine the extent of sequence variation, and to establish whether particular genome types correlate with any of the different clinical manifestations of B19 infection.
METHODS
Virus. B19 isolates were from the collection of virus-positive sera held in the Virus Reference Laboratory. The designation of each serum used is given in Table 2 .
Nucleic acid analysis. Serum (0.5 ml) or plasma samples were layered on 4.5 ml l 5 to 30% (w/v) sucrose gradients (in 20 mM-Tris-HC1, 2 mM-EDTA, 150 mM-NaC1, pH 7.5) and centrifuged at 40000 r.p.m, for 5 h in a Beckman SW50.1 rotor at 5 °C. The pellet was resuspended by sonication in 100 pl 5 mM-EDTA, 10 mM-Tris-HC1 pH 7.8, and DNA was prepared by proteinase K digestion and phenol extraction. Restriction enzyme digestions were performed with 0.1 lag DNA in 20 pl of the recommended buffer for 1.5 h at 37 °C. D N A was analysed on 1 agarose gels which, when necessary, were transferred to nylon membranes by capillary blotting following the manufacturer's recommendations (Hybond-N, Amersham). Hybridization was with 106 c.p.m./ml 32p-labelled nick-translated B19 DNA. This was prepared from a molecular clone of a 5.2 kb insert (Fig. 1 , lane 11) of isolate JB (see Table 2 ) virion DNA in the vector pGEM-1. Electron microscopy. DNA from the B19 isolates JB and Br II (Table 2 ) was examined. It was spread on grids following the method of Davis et al. ( 1971) , and examined with an Elmiskop 1A (Siemens) working at 80 kV. M 13 DNA was used as a single-stranded standard, pAT153 DNA as a double-stranded standard. The lengths of 35 molecules in each of the two preparations were measured using a Ferranti Cetec Digitiser and an Olivetti P6040 computer. One ~tg of JB DNA was also examined after digestion with either 1 unit of nuclease S1 for 1 h at 40 °C, or with 0.01 unit of Bal31 for 1 min at room temperature. DNA from the Br II isolate was also examined after denaturation and renaturation. NaOH and EDTA were added to final concentrations of 0.1 M and 0.02 M respectively, and the solution was incubated for 10 min at 27 °C before neutralization with 1/9 vol. of 2 M-Tris, 1.6 M-HC1. An equal volume of formamide was added, and the DNA was allowed to renature for 1.5 h before dilution in 20 vol. of 0-01 M-Tris, 0.001 M-EDTA, pH 8.5.
RESULTS

Nucleic acid extraction
All serum specimens from which B19 virus was prepared yielded a major band of virion DNA of 5.5 kb (Fig. 1) . Occasionally, slower migrating forms of DNA were also seen (Fig. 1 , lanes 7 Electron microscopy On examination of D N A preparations by electron microscopy, linear molecules with distinctive terminal structures were seen (Fig. 2 ). The distribution of these different forms in the population of molecules was determined (Table 1 a). Some had a forked structure at both ends, an almost equal number had a fork at only one end, and about one-sixth of the molecules lacked them altogether. The number of forked ends was unaffected by treatment with S1 nuclease but was dramatically reduced by Bal31 digestion. A similar effect was observed following denaturation and renaturation. In addition to linear molecules (with or without forked ends) other forms were seen including networks of D N A (Fig. 3) . The number of these forms was reduced both by Bal31 digestion and by denaturation and renaturation. By comparison with known standards the lengths of a small number of D N A molecules, and their forks, were determined (Table 1 b ). The effect of Bal31 digestion was also monitored by gel electrophoresis (Fig. 4) . Early time points of digestion showed a ladder of discrete D N A fragments, with the first fragment being approximately 100 bp shorter than the intact viral genome. 
Restriction mapping
DNA from any one isolate was digested with up to 13 different enzymes (Fig. 5) , and double digests were performed to establish physical maps of the cutting sites of the enzymes. EcoRI, XhoI and SalI were not found to cut any of the DNAs tested, and the majority were not cut by XbaI. The other enzymes cut at one to three places (Table 2) . Some enzymes gave an unvarying cutting pattern on all isolates tested (HindIII, BamHI, BglII, BstEII) . The map of Cossart's original B19 isolate is shown in Fig. 6 and was used as the reference or prototype for comparative analysis. Isolates with the same restriction enzyme pattern as the prototype were assigned to a group designated I (Table 2) . A second virus type (group II) had an additional HpaI site compared with the prototype. The group IIIa viruses had an additional PvuII site as well as the additional HpaI site compared with the prototype virus. The group IIIb viruses also had this additional Hpal site, as well as having an extra KpnI site. Four isolates from Japan (group IV) had extra PstI and XbaI sites and, compared to the prototype, lacked a PvuII site.
DISCUSSION
The forks seen at the ends of B19 DNA are presumably due to terminal repeat sequences folding back on themselves. The estimated size of the forks observed (120 to 130 bases) is consistent with the predicted nucleotide length (Shade et al., 1986) . However, the termini have not yet been fully sequenced due to their instability in plasmid vectors (Shade et al., 1986) . These repeats are thought to be larger than those known for any other parvovirus, including the adenoassociated viruses (AAV) (Astell et al., 1979; Lusby et al., 1980) . This large size probably accounts for the ability to visualize the fold-back termini by electron microscopy. These have not been observed with other Parvoviridae. The terminal sequences were sequentially removed by Bal3l treatment, as can be seen in Fig. 4 . The extent of Ba131 digestion was estimated to be about 100 bp after 0.5 min, to 500 bp at 2-25 to 5 min (Fig. 4) . Far fewer forked structures were seen by electron microscopy after denaturation and renaturation of the D N A (Table 1 a) . This was also the case after prolonged storage of D N A at 4 °C (results not shown). This implies that, under suitable conditions, hydrogen bonding between terminal complementary sequences on opposite strands can replace that between palindromic sequences on the same strand. This assumption is supported by the length measurements, even though only 70 molecules were measured. For each D N A preparation considered separately, the molecules with no forks were on average the longest, whereas those with a fork at only one end were slightly shorter, and those with two forks were the shortest (Table 1 b) .
The significance of this D N A structure is at present unclear, but may be related to the phenomenon of D N A strands of either polarity being encapsidated in the virion. One other autonomous parvovirus, LulII, also packages both strands (Muller & Siegl, 1983) , and further studies of its genome may help elucidate the function of such terminal structures. Homologous terminal sequences should allow the formation of single-stranded open circular forms with 'panhandles', as was observed in reannealing experiments with AAV D N A (Gerry et al., 1973) , but such structures were not observed in the present study. It is not possible to predict whether I  2  1  2  0  1  2  3  1  1  1  0  0  0   II  2  1  2  0  1  3  3  1  1  1  0  0  0  IIIa  2  1  3  0  1  3  3  1  1  1  0  0  0  IIIb  2  1  2  0  2  3  3  1  1  1  0  0  0  IV  3  1  1  1  1  2  3  1  1  1  0  0  0  Unassigned  3  2  2  1  0  2  3  1  I  1  0  0  0  3  1  2  2  2*  2  3  1  1  1  0  0  0  3  1  2  1  1  2  3  1  I  1 have not yet been determined. Networks of DNA were seen (Fig. 3 ) and these are probably responsible for the bands sometimes observed (Fig. 1 ) that migrated more slowly than duplex B19 DNA. The high yield of ds viral DNA from clinical serum specimens permitted restriction enzyme analysis of B19 virus. This has allowed strain variation to be studied in antigenically identical B19 isolates, as has been done for adenovirus isolates of the same serological type (Wadell, 1984) . The restriction map of the prototype B19 was found to be identical with that of five other isolates (group I). These were all found in blood donations, with the earliest being obtained in the U.K. in 1973 and the most recent from France in 1979. The majority of the isolates mapped by Morinet et al. (1986) probably fall into this group, although fewer enzyme sites were mapped by those workers. Thus a single virus genome type can remain in circulation over a 6 year period. However, if all of the group I isolates could be sequenced, variation would probably be observed. The group II genome type has been in circulation from 1978 in France to 1986 in the U.K. From 1979 to 1986 a virus with a third restriction pattern has been in circulation in the U.K. (group IIIa). The group IIIb genome type was first seen in blood from a donor in France in 1978 and lately from a case of aplasia in Scotland in 1986. Obviously, virus types with other maps have been in circulation for as long as it has been possible to observe. As can be seen from Fig. 6 , restriction sites were observed over the entire genome, and it is not yet possible to determine if any one region is more or less highly conserved, One reason for this study was to attempt to determine whether one genome type could be correlated with a particular clinical manifestation of infection. As shown in Table 2 this is apparently not the case. The group II genome type, for instance, was associated with not only a rash, but also purpura, aplasia and arthralgia. This conclusion is supported by the observation that various clinical manifestations of B 19 infection can occur in the same patient (Nunoue et al., 1987) , in closely related family groups (Lefrere et al., 1985a) , and in community-wide outbreaks of infection (Chorba et al., 1986) . The different outcomes of B19 infection are more easily explained by the multiplication of the virus in genetically different hosts. There is, for example, a distinct clinical outcome of B19 infection if the host has an inherited red cell disorder, i.e. the aplastic crisis of sickle cell anaemia. Blundell et al. (1987) determined the nucleotide sequence of two B19 isolates and found only 41 base differences, a variation of less than 1 ~. The present observations suggest that there is a similar amount of sequence divergence between our 47 isolates. Thus, the genome of B19 appears to be highly conserved. Further insight into its genetic variation will be obtained when more virus-positive specimens are analysed. At present, this is dependent on DNA extracted from infected serum as there is no available cell culture system. This, however, has the advantage that the possibility of genetic variation due to adaptation to culture cannot occur (Bloom et al., 1987) . Molecular cloning of viral DNA from infected serum will provide a source of the majority of genomic B19 DNA, apart from the inverted repeats. Cloning experiments should also allow the development of the in vitro expression systems for the production of viral antigens needed for diagnosis and possible vaccine production.
